近視および老眼治療の世界市場レポート 2025年

近視および老眼治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で314億3,000万米ドルに成長します。予測期間の成長は、眼疾患に対する遺伝子治療の出現、ライフスタイル向上のための視力矯正への注目、オルソケラトロジーの採用拡大、アイケア習慣に影響を与える文化的要因、予防的アイケアへのシフトなどに起因すると考えられます。予測期間の主な動向には、視力ケアのための遠隔医療、薬剤介入、カスタマイズコンタクトレンズ、近視抑制装置、高度眼内レンズ（IoLS）、老眼の屈折矯正手術、レンズ移植技術などがあります。

老年人口（特に65歳以上）の増加が予測されており、近視および老眼治療市場の成長を促進すると予測されています。この人口層は、加齢に伴う脆弱性や免疫力の低下により、近視や老眼を含む目に関連する病気のリスクが高まっています。これらの疾患を対象とした治療には、しばしば眼の視覚的および顕微鏡的要素の徹底的な検査が含まれ、高齢者の間で流行している様々な眼関連疾患の特定と管理に役立っています。世界保健機関（WHO）の2022年10月の報告書によると、2030年までに世界の6人に1人が60歳以上になり、2050年までに世界の60歳以上の人口は21億人に達すると推定されています。

視力障害の罹患率の高まりは、近視および老眼治療市場の成長を促進すると考えられています。視力障害は、視覚的解釈能力の低下を特徴とし、周囲の環境を知覚・理解する上で課題をもたらします。この動向は治療法の開発に拍車をかけ、この分野への意識の高まり、技術革新、投資を促すと予想されます。2023年8月に米国疾病予防管理センターが発表した報告書によると、米国では2050年までに視力障害が896万人に増加すると予測されています。この増加の要因としては、糖尿病などの慢性疾患の蔓延や高齢化が挙げられます。さらに、米国では18歳未満の子供の約6.8%が眼や視覚の問題を抱えていると診断されており、視覚の問題を抱えるさまざまな年齢層に対応する効果的なソリューションの必要性が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の近視および老眼治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の近視および老眼治療市場：成長率分析
• 世界の近視および老眼治療市場の実績：規模と成長, 2019-2024
• 世界の近視および老眼治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の近視および老眼治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の近視および老眼治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 近視
• 老眼
• 世界の近視および老眼治療市場：近視治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 矯正
• 外科手術
• 薬剤
• 世界の近視および老眼治療市場：老眼治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方レンズ
• コンタクトレンズ
• 眼内レンズ
• 屈折矯正手術
• 世界の近視および老眼治療市場：近視のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 眼鏡とコンタクトレンズ
• 屈折矯正手術
• 薬物療法
• オルソケラトロジー
• 世界の近視および老眼治療市場：老眼のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 多焦点眼鏡
• 遠近両用コンタクトレンズ
• 老眼矯正手術
• 薬物療法

第7章 地域別・国別分析

• 世界の近視および老眼治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の近視および老眼治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 近視および老眼治療市場：競合情勢
• 近視および老眼治療市場：企業プロファイル
  • ALCON Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Carl Zeiss AG Overview, Products and Services, Strategy and Financial Analysis
  • Essilor Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Hagg Striet UK Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Johnson & Johnson Vision Inc.
• Nidek Corporation
• Topcon Corporation
• Zimmer Ophthalmic Systems AG
• AbbVie Inc.
• Orasis Pharmaceuticals Ltd.
• Regeneron Pharmaceuticals Inc.
• Sydnexis Inc.
• The Cooper Companies Inc.
• Staar Surgical Co.
• Eyenovia Inc.
• Allergan PLC
• Hoya Corporation
• Novartis AG
• Menicon Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 近視および老眼治療市場2029：新たな機会を提供する国
• 近視および老眼治療市場2029：新たな機会を提供するセグメント
• 近視および老眼治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Myopia and presbyopia treatment encompasses procedures or therapies aimed at rectifying and enhancing vision affected by myopia and presbyopia, both in adults and children. The primary objective revolves around diagnosing underlying conditions, mitigating injury risks, alleviating ocular symptoms, and early detection of these eye conditions.

The main focus of myopia and presbyopia treatment is on two specific eye conditions such as myopia and presbyopia. Myopia involves visual images focusing in front of the retina, resulting in reduced clarity when viewing distant objects. Treatments for myopia cater to both adults and children, encompassing corrective measures, surgical interventions, and pharmaceutical approaches. On the other hand, presbyopia treatment methods comprise prescription lenses, contact lenses, intraocular lenses, and refractive surgeries, specifically targeting presbyopia-related visual impairments.

The myopia and presbyopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia and presbyopia treatment market statistics, including myopia and presbyopia treatment industry global market size, regional shares, competitors with a myopia and presbyopia treatment market share, detailed myopia and presbyopia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the myopia and presbyopia treatment industry. This myopia and presbyopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myopia and presbyopia treatment market size has grown strongly in recent years. It will grow from $21.04 billion in 2024 to $22.7 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of myopia and presbyopia, awareness and education initiatives, shift in lifestyles and screen time, consumer preference for non-surgical treatments, economic growth and healthcare spending, clinical research and development, accessibility to eyecare services.

The myopia and presbyopia treatment market size is expected to see strong growth in the next few years. It will grow to $31.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to emergence of gene therapies for eye disorders, focus on vision correction for lifestyle enhancement, growing adoption of orthokeratology, cultural factors impacting eyecare practices, shift towards preventive eyecare. Major trends in the forecast period include telemedicine for vision care, pharmaceutical interventions, customized contact lenses, myopia control devices, advanced intraocular lenses (IoLS), refractive surgery for presbyopia, and lens implant technologies.

The projected rise in the geriatric population, specifically individuals aged 65 and above, is anticipated to propel the growth of the myopia and presbyopia treatment market. This demographic segment, due to age-related vulnerabilities and lowered immunity, experiences heightened risks of eye-related ailments, including myopia and presbyopia. Treatments targeting these conditions often involve thorough examination of the visual and microscopic elements of the eye, aiding in the identification and management of various eye-related illnesses prevalent among the elderly. According to the World Health Organization's October 2022 report, by 2030, one in six individuals globally will be 60 or older, and by 2050, the worldwide population aged 60 or above is estimated to reach 2.1 billion, indicating a substantial surge in demand for treatments addressing age-related vision issues.

The escalating incidence of vision impairment is poised to drive growth in the myopia and presbyopia treatment market. Vision impairment, characterized by reduced visual interpretative abilities, poses challenges in perceiving and comprehending the surrounding environment. This trend is anticipated to spur the development of treatments, encouraging heightened awareness, innovation, and investments in the field. Notably, a report from the Centers for Disease Control and Prevention in August 2023 highlights a projected increase in vision impairment cases to 8.96 million by 2050 in the United States. Factors contributing to this rise include the prevalence of chronic diseases like diabetes and an aging population. Moreover, approximately 6.8% of children under 18 in the U.S. have been diagnosed with eye and vision issues, emphasizing the need for effective solutions catering to various age groups experiencing visual challenges.

Technologically advanced solutions are a key trend gaining traction in the myopia and presbyopia treatment market. Major companies are focusing on developing innovative solutions to maintain their competitive edge. For instance, in September 2024, Entod Pharmaceuticals, an India-based manufacturing company, launched PresVu Eye Drops, marking the first eye drop in India specifically formulated for treating presbyopia, a common age-related vision condition that typically affects individuals over 40 years old. Approved by the Drug Controller General of India (DCGI), PresVu is designed to reduce the reliance on reading glasses while providing lubrication to the eyes. These eye drops employ advanced dynamic buffer technology, ensuring consistent efficacy and safety for prolonged use.

Companies in the myopia and presbyopia treatment sector are innovating products, such as myopia-combating sun spectacle lenses, to broaden their customer base and drive revenue growth. Notably, in May 2023, HOYA launched MiYOSMART sun spectacle lenses, designed to mitigate myopia progression in children. These lenses, incorporating DIMS Technology, offer specialized options like MiYOSMART Chameleon and MiYOSMART Sunbird, aiming to slow myopia progression while providing sunlight protection. This technology, developed in collaboration with the Hong Kong Polytechnic University, introduces defocus elements to regulate myopia progression during outdoor activities. The market's emphasis on innovation aligns with emerging evidence supporting outdoor time as a preventive measure against myopia, emphasizing the significance of encouraging outdoor engagements for myopic children.

In January 2024, Eyenovia Inc., a US-based ophthalmic pharmaceutical technology company, acquired the development and commercialization rights for MicroPine from Bausch + Lomb Ireland Limited for an undisclosed amount. The purpose of this acquisition is to accelerate the commercialization of advanced ophthalmic products, specifically aimed at treating pediatric progressive myopia, thus enhancing their late-stage pipeline and addressing a significant unmet medical need in the U.S. and Canada. Bausch + Lomb Ireland Limited is an Ireland-based eye health company involved in the development of MicroPine for myopia treatment.

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Hagg Striet UK Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Sydnexis Inc., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Novartis AG, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, Ophthotech Corporation, OphthaliX Inc., LensGen Inc., Lightico Ltd., RxSight Inc., Perfect Lens LLC

North America was the largest region in the myopia and presbyopia treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myopia and presbyopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia and presbyopia treatment market includes revenues earned by entities by performing refractive surgery, lens implants, bifocal surgery services and providing eye sight management treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia and Presbyopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia and presbyopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia and presbyopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myopia and presbyopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Myopia; Presbyopia
• 2) By Myopia Treatment Type: Corrective; Surgical; Drugs
• 3) By Presbyopia Treatment Type: Prescription Lenses; Contact Lenses; Intraocular Lenses; Refractive Surgery
• Subsegments:
• 1) By Myopia: Eyeglasses And Contact Lenses; Refractive Surgery; Pharmacological Treatments; Orthokeratology
• 2) By Presbyopia: Multifocal Eyeglasses; Bifocal Contact Lenses; Presbyopia-Correcting Surgery; Pharmacological Treatments
• Companies Mentioned: ALCON Inc.; Bausch & Lomb Incorporated; Carl Zeiss AG; Essilor Ltd.; Hagg Striet UK Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myopia and Presbyopia Treatment Market Characteristics

3. Myopia and Presbyopia Treatment Market Trends And Strategies

4. Myopia and Presbyopia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Myopia and Presbyopia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Myopia and Presbyopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Myopia and Presbyopia Treatment Market Growth Rate Analysis
• 5.4. Global Myopia and Presbyopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Myopia and Presbyopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Myopia and Presbyopia Treatment Total Addressable Market (TAM)

6. Myopia and Presbyopia Treatment Market Segmentation

• 6.1. Global Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myopia
• Presbyopia
• 6.2. Global Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corrective
• Surgical
• Drugs
• 6.3. Global Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Lenses
• Contact Lenses
• Intraocular Lenses
• Refractive Surgery
• 6.4. Global Myopia and Presbyopia Treatment Market, Sub-Segmentation Of Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eyeglasses And Contact Lenses
• Refractive Surgery
• Pharmacological Treatments
• Orthokeratology
• 6.5. Global Myopia and Presbyopia Treatment Market, Sub-Segmentation Of Presbyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multifocal Eyeglasses
• Bifocal Contact Lenses
• Presbyopia-Correcting Surgery
• Pharmacological Treatments

7. Myopia and Presbyopia Treatment Market Regional And Country Analysis

• 7.1. Global Myopia and Presbyopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Myopia and Presbyopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myopia and Presbyopia Treatment Market

• 8.1. Asia-Pacific Myopia and Presbyopia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myopia and Presbyopia Treatment Market

• 9.1. China Myopia and Presbyopia Treatment Market Overview
• 9.2. China Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myopia and Presbyopia Treatment Market

• 10.1. India Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myopia and Presbyopia Treatment Market

• 11.1. Japan Myopia and Presbyopia Treatment Market Overview
• 11.2. Japan Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myopia and Presbyopia Treatment Market

• 12.1. Australia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myopia and Presbyopia Treatment Market

• 13.1. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myopia and Presbyopia Treatment Market

• 14.1. South Korea Myopia and Presbyopia Treatment Market Overview
• 14.2. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myopia and Presbyopia Treatment Market

• 15.1. Western Europe Myopia and Presbyopia Treatment Market Overview
• 15.2. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myopia and Presbyopia Treatment Market

• 16.1. UK Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myopia and Presbyopia Treatment Market

• 17.1. Germany Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myopia and Presbyopia Treatment Market

• 18.1. France Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myopia and Presbyopia Treatment Market

• 19.1. Italy Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myopia and Presbyopia Treatment Market

• 20.1. Spain Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myopia and Presbyopia Treatment Market

• 21.1. Eastern Europe Myopia and Presbyopia Treatment Market Overview
• 21.2. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myopia and Presbyopia Treatment Market

• 22.1. Russia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myopia and Presbyopia Treatment Market

• 23.1. North America Myopia and Presbyopia Treatment Market Overview
• 23.2. North America Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myopia and Presbyopia Treatment Market

• 24.1. USA Myopia and Presbyopia Treatment Market Overview
• 24.2. USA Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myopia and Presbyopia Treatment Market

• 25.1. Canada Myopia and Presbyopia Treatment Market Overview
• 25.2. Canada Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myopia and Presbyopia Treatment Market

• 26.1. South America Myopia and Presbyopia Treatment Market Overview
• 26.2. South America Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myopia and Presbyopia Treatment Market

• 27.1. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myopia and Presbyopia Treatment Market

• 28.1. Middle East Myopia and Presbyopia Treatment Market Overview
• 28.2. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myopia and Presbyopia Treatment Market

• 29.1. Africa Myopia and Presbyopia Treatment Market Overview
• 29.2. Africa Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myopia and Presbyopia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Myopia and Presbyopia Treatment Market Competitive Landscape
• 30.2. Myopia and Presbyopia Treatment Market Company Profiles
  • 30.2.1. ALCON Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Carl Zeiss AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Essilor Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hagg Striet UK Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Myopia and Presbyopia Treatment Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson Vision Inc.
• 31.2. Nidek Corporation
• 31.3. Topcon Corporation
• 31.4. Zimmer Ophthalmic Systems AG
• 31.5. AbbVie Inc.
• 31.6. Orasis Pharmaceuticals Ltd.
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Sydnexis Inc.
• 31.9. The Cooper Companies Inc.
• 31.10. Staar Surgical Co.
• 31.11. Eyenovia Inc.
• 31.12. Allergan PLC
• 31.13. Hoya Corporation
• 31.14. Novartis AG
• 31.15. Menicon Co. Ltd.

32. Global Myopia and Presbyopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia and Presbyopia Treatment Market

34. Recent Developments In The Myopia and Presbyopia Treatment Market

35. Myopia and Presbyopia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Myopia and Presbyopia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Myopia and Presbyopia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Myopia and Presbyopia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer